Cameron Turtle

Insider Reports History

Location
Waltham, MA
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Turtle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spyre Therapeutics, Inc. Chief Executive Officer, Director Common Stock 687K $20.5M $29.83 01 Dec 2025 Direct
Oruka Therapeutics, Inc. Director Common Stock 85.2K $254K $2.98 29 Aug 2024 By Turtle Family Trust
Spyre Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 370K 15 Jan 2025 Direct
Oruka Therapeutics, Inc. Director Stock Option (right to buy) 17.5K 02 Jun 2025 Direct

Insider Reports Filed by Cameron Turtle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRE Spyre Therapeutics, Inc. 01 Dec 2025 2 -$435K 4 Chief Executive Officer, Director 03 Dec 2025, 21:52
SYRE Spyre Therapeutics, Inc. 03 Nov 2025 2 -$1.05M 4 Chief Executive Officer, Director 05 Nov 2025, 21:15
ORKA Oruka Therapeutics, Inc. 02 Jun 2025 1 $0 4 Director 03 Jun 2025, 16:13
SYRE Spyre Therapeutics, Inc. 15 Jan 2025 1 $0 4 Chief Executive Officer, Director 17 Jan 2025, 16:35
ORKA Oruka Therapeutics, Inc. 29 Aug 2024 0 $0 3 Director 06 Sep 2024, 17:07
SYRE Spyre Therapeutics, Inc. 15 Feb 2024 1 $3.93K 4 Chief Executive Officer, Director 20 Feb 2024, 21:21
SYRE Spyre Therapeutics, Inc. 01 Feb 2024 1 $0 4 Chief Executive Officer, Director 02 Feb 2024, 20:31
AGLE Spyre Therapeutics, Inc. 22 Nov 2023 3 $0 4 Chief Executive Officer, Director 27 Nov 2023, 16:25
AGLE Aeglea BioTherapeutics, Inc. 22 Jun 2023 0 $0 3 Chief Operating Officer 30 Jun 2023, 17:14